Popular

• 

  RestartResume

  ILD in Rheumatic Diseases: Evolving Management Strategies

  Living Rheum

  ILD in Rheumatic Diseases: Evolving Management Strategies

• 

  RestartResume

  CAR T-Cell Therapy: New Frontiers in Diffuse Systemic Sclerosis Treatment

  Living Rheum

  CAR T-Cell Therapy: New Frontiers in Diffuse Systemic Sclerosis Treatment

• 

  RestartResume

  Artificial Intelligence in Dermatology: Exploring New Diagnostic Strategies

  Clinician's Roundtable

  Artificial Intelligence in Dermatology: Exploring New Diagnostic Strategies

• 

  RestartResume

  Postbiotics and Microneedling: An Emerging Approach for Acne Relief 

  Clinician's Roundtable

  Postbiotics and Microneedling: An Emerging Approach for Acne Relief 

• 

  RestartResume

  Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis, and Management

  CME/CE

  Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis, and Management

  • 

    

    Saurabh Malhotra, MD, MPH

    Peer

  • 

    

    Kevin Alexander, MD

    Peer

  • 

    

    Tawfiq Al-lahham, MD

    Peer

  • 

    

    Sarah Cuddy, MD

    Peer

  • 

    

    Angela Dispenzieri, MD

    Peer

  • 

    

    Anita D’Souza, MD

    Peer

  • 

    

    Foluso Fakorede, MD

    Peer

  • 

    

    Mazen Hanna, MD

    Peer

  • 

    

    Isabelle Lousada

    Peer

  • 

    

    Ahmad Masri, MD, MS

    Peer

  • 

    

    Mathew S. Maurer, MD

    Peer

  • 

    

    Matthew Parker, MD

    Peer

  • 

    

    Frederick Ruberg, MD

    Peer

  • 

    

    Andrew Staron, MD

    Peer

  • 

    

    Prem Soman, MD, PhD

    Peer

  • 

    

    Jonathan Wall, PhD

    Peer

  • 

    

    Ashutosh Wechalekar, MBBS, MD

    Peer

  • 

    

    Panithaya Chareonthaitawee, MD

    Peer

• 

  RestartResume

  Improving Postsurgical Outcomes in Crohn’s Disease

  GI Insights

  Improving Postsurgical Outcomes in Crohn’s Disease

  • 

    

    Elisa K. Boden, MD

    Peer

• 

  RestartResume

  NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy 

  NeuroFrontiers

  NKX019: A Potential New Frontier in Generalized Myasthenia Gravis Therapy 

• 

  RestartResume

  Acute Kidney Injury in Cirrhosis: Multidisciplinary Decision-Making

  CME/CE

  Acute Kidney Injury in Cirrhosis: Multidisciplinary Decision-Making

  • 

    

    Nancy S. Reau, MD

    Peer

  • 

    

    Andrew Allegretti, MD, MSc

    Peer

  • 

    

    Kevin Regner, MD

    Peer

  • 

    

    Ram Subramanian, MD

    Peer

  0.50 credits

• 

  RestartResume

  No Patient Left Behind! Advancing CKD-Associated Pruritus Care

  CME/CE

  No Patient Left Behind! Advancing CKD-Associated Pruritus Care

  • 

    

    Kieran McCafferty, MD

    Peer

  • 

    

    Maurizio Gallieni, MD

    Peer

  0.25 credits

• 

  RestartResume

  A Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies

  CME/CE

  A Clear Horizon in Plaque Psoriasis: Exploring the Role of Investigational Oral Therapies

  0.25 credits

• 

  RestartResume

  Objective Measures and Endoscopic Improvement

  Medical Industry Feature

  Objective Measures and Endoscopic Improvement

  • 

    

    David T. Rubin, MD

    Peer

  • 

    

    Oriana Damas, MD, MSCTI

    Peer

• 

  RestartResume

  Molecular Profiling for HER2+ Advanced Solid Tumors

  CME/CE

  Molecular Profiling for HER2+ Advanced Solid Tumors

  • 

    

    Eric Van Cutsem, MD, PhD

    Peer

  • 

    

    David SP Tan, MBBS, PhD, PRCP

    Peer

  • 

    

    James Chih-Hsin Yang, MD, PhD

    Peer

  • 

    

    Kathleen Moore, MD, MS, FASCO

    Peer

  1.00 credits

• 

  RestartResume

  Help Protect Your Older Patients This Flu Season: Examining Real-World Data

  Medical Industry Feature

  Help Protect Your Older Patients This Flu Season: Examining Real-World Data

  • 

    

    Charles Turck, PharmD, BCPS, BCCCP

    Peer

  • 

    

    Stephen I. Pelton, MD

    Peer

• 

  RestartResume

  Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model 

  CME/CE Broadcast Replay

  Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model 

  • 

    

    Melissa Magwire, RN, MSN, CDE

    Peer

  • 

    

    Matthew Bullington, PharmD

    Peer

  • 

    

    Dawn M. Denicola, FNP-C

    Peer

  • 

    

    Keith Miller, MD

    Peer

  1.00 credits

• 

  RestartResume

  TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management

  CME/CE

  TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management

  • 

    

    James R. Bateman, MD, MPH

    Peer

  • 

    

    Jerome A. Barakos, MD

    Peer

  • 

    

    Danya Khoujah, MBBS, MEHP, FACEP, FAAEM

    Peer

  • 

    

    B. Joy Snider, MD, PhD

    Peer

  0.50 credits